Carcinogenesis by oncogenic Ras and Her-2 involves enhanced proliferation of epithelial cells in vivo. However, hyperproliferation induced by these oncogenes, or their downstream pathways in vitro has mainly been studied in cultured, fibroblastic cell lines. Here, we demonstrate that oncogenic Ha-Ras or constitutively active Her-2 cause increased proliferation and cyclin D1 upregulation in fully polarized, mammary epithelial cells (EpH4), if cultivated as organotypic structures in three-dimensional collagen/ matrigel matrices. Under standard culture conditions, however, these oncogenes failed to induce hyperproliferation. Using both specific low molecular weight inhibitors and Ras-effector -specific mutants, we dissected signaling pathways downstream of oncogenic Ras (PI3K, Mek1/ MAPK) with respect to (i) hyperproliferation in collagen gels and tumorigenesis in mice and (ii) epithelial/ mesenchymal transition (EMT). We show that the Rasactivated PI3K pathway is required to induce rapid tumor growth and enhanced proliferation of EpH4 cells in collagen gels, but fails to cause EMT in vitro and in vivo. On the other hand, Ras-dependent activation of the Mek1/ MAPK pathway in EpH4 cells (previously shown to cause EMT and metastasis) did not induce hyperproliferation in collagen gels and caused only slow tumor growth. Our data thus indicate that Ras-dependent signaling through the PI3K-and MAPK pathways fulfil distinct, but complementary functions during carcinogenesis.
Introduction
A large body of biochemical and genetic evidence identified Ras as a key regulator of both cellproliferation and -differentiation in metazoans. The temporary coincidence between growth factor-induced nuclear translocation of MAPK/Erk and initiation of S phase led to the concept that the Raf/MAPK pathway is the primary mediator of the Ras-dependent mitogenic response. In support of that, microinjected Raf proteins induced proliferation in quiescent fibroblasts (Smith et al., 1990) . Oncogenic Raf also caused fibroblast transformation with similar potency as activated Ras (Cowley et al., 1994; Mansour et al., 1994) . Similarly, moderate, conditional activation of RafER and MEK-1ER fusion proteins by appropriate hormone ligand levels induced DNA synthesis and transformation in fibroblasts (Pritchard et al., 1995; Treinies et al., 1999; Woods et al., 1997) .
Identification of PI3K, however, as an additional, important mediator of oncogenic Ras signals led to a new model in which Raf/MAPK-and PI3K pathways cooperate to cause mitogenic stimulation (Joneson et al., 1996) and a fully transformed phenotype in vitro (Rodriguez-Viciana et al., 1997) . Furthermore, both direct activation of MEK-1 and indirect activation of the PI3K/PKB pathway via Ras/Raf-induced autocrine loops of receptor tyrosine kinase ligands contributed to induction of DNA synthesis (Schulze et al., 2001; Treinies et al., 1999) .
Multiple mechanisms have been proposed on how the Raf/Erk-and PI3K pathways may signal to the cell cycle machinery. The cyclin D1 promoter can be activated by multiple Ras effectors in an additive or even synergistic fashion (Gille and Downward, 1999) . Ras has been shown to enhance cyclin D1 protein levels through the Raf/MAPK pathway (Peeper et al., 1997) , while PI3K influences protein stability of cyclin D1, through Akt and S6K (Diehl et al., 1998) . Akt also inactivates GSK3, which promotes degradation of cyclin D1 through phosphorylation. The PI3K-and Erk pathways synergistically regulate the stability and thus accumulation of the c-myc protein via phosphorylation of distinct Ser and Thr residues (Sears et al., 2000) . Finally, activation of PKB-Akt by oncogenic Her-2 (an EGF receptor family member that acts upstream of Ras) causes the phosphorylation of p21 CIP/WAF thereby preventing its nuclear translocation required for cell cycle inhibition (Zhou et al., 2001) .
It remains unclear, however, to what extent these different mechanisms contribute to proliferation regulation by oncogenic Ras or Her-2 and whether different cell types employ distinct, predominant pathways. In addition, little is known about proliferation control by Ras or downstream pathways in polarized, primary cell-like epithelial cells, since most work relevant to this question has been performed using fibroblast cell lines or transformed, non-or aberrantly polarized epithelial cells under standard culture conditions (serum/plastic dishes). For instance, studies analysing Her2/Erb-B2 downstream signaling in vivo in MMTV-Her2 transgenic mouse models (Dankort and Muller, 2000) were correlated to mechanistic, biochemical studies in Rat-1 fibroblasts (Dankort et al., 2001) or dedifferentiated breast cancer tumor cell lines (Lee et al., 2000) . In contrast, epithelial cell proliferation by oncogenes has not yet been analysed in fully polarized, epithelial cell lines allowed to form in vivo-like organotypic structures under special, three dimensional culture conditions (Montesano et al., 1998; Oft et al., 1996) . In addition, little is known about the question which Ras/Her2 downstream signaling pathways are most important for enhanced proliferation during tumorigenesis, and whether these pathways can be distinguished from those mediating invasive responses such as epithelial/ mesenchymal transition (EMT) and metastasis. In several systems, EMT and metastasis were shown to require a cooperation of overexpressed, oncogenic Ras or Raf with endogenous transforming growth factor b (TGFb), acting through TGFb autocrine loops (Lehmann et al., 2000; Oft et al., 1996 Oft et al., , 1998 . The respective Ras downstream pathway required for EMT and metastasis was recently identified as the Mek/ MAPK pathway (Janda et al., 2002) .
In this study, we employ a well-characterized, combined in vitro -in vivo cell system to demonstrate that polarized mammary epithelial cells transformed by oncogenic Ras or Her-2 undergo hyperproliferation in three dimensional collagen gels containing matrigel (3D cultures), correlated to rapid tumor growth in vivo. This Ras-dependent hyperproliferation cannot be detected in standard tissue culture on plastic (2D cultures). We also show that the Ras-activated PI3K signaling pathway is required and sufficient for epithelial cell hyperproliferation in 3D cultures. The MAPK-pathway, likewise hyperactivated by oncogenic Ras, causes EMT in vitro and in vivo, but fails to cause epithelial cell hyperproliferation, mirrored by slow growth of tumors. Thus, proinvasive and proliferogenic effects of the Ras-oncogene in mammary carcinogenesis can be mechanistically dissected.
Results
Collagen gels are required to detect differences in proliferation between normal and oncogene-expressing EpH4 cells
In fibroblasts (Liu et al., 1995) and certain epithelial cell systems (Filmus et al., 1994) , tumorigenesis induced by oncogenic Ras was correlated to G1 shortening, increased proliferation in vitro and activation of cyclin D1 expression. Oncogenic Ras also induces non-tumorigenic, fully polarized mammary epithelial cells (EpH4) to form rapidly growing tumors in mice (Oft et al., 1996) , but this has not been correlated to potential Ras effects on proliferation of these cells in culture. Therefore, we sought to determine, whether enhanced proliferation in cell culture and rapid tumor formation in vivo were correlated in a set of tumorigenic EpH4-derived clones or mass cultures expressing different variants of oncogenic Ras as well as a constitutively active EGFreceptor 2 (Her-2 * , Pacher et al., in preparation). Aliquots from these Ras-or Her-2 * -transformed cells were injected into nude mice and tumor size determined after 4 weeks, using empty vector transfected EpH4 cell clones and pools as non-tumorigenic controls ( Figure 1a) . Aliquots from the same cell populations were tested in 2D and 3D cultures, i.e. on plastic (3D) in 2% serum (to enhance possible oncogene effects on proliferation), or in serum-free collagen gels (3D) supplemented with 10% matrigel and various growth factors (see Oft et al., 1996) . Cell proliferation was measured by determining [
3 H]-thymidine (TdR) incorporation ( Figure 1b ). All Rasor Her-2 * -expressing cells showed clearly enhanced proliferation in 3D collagen gel cultures, manifested by accumulation of polarized, branched and hollow tubules that entirely filled the collagen matrices (data not shown). In contrast, only few, rather thin structures were formed by the non-transformed EpH4 cells. Interestingly, these differences in the rates of DNA synthesis and tubule formation obtained with the various cell types in 3D cultures correlated well with their ability to form tumors in mice (Figure 1a) .
In contrast, the same cells analysed on plastic showed comparable levels of [ 3 H]-TdR incorporation, a less than twofold increase being detected only in one clone of v-H-Ras transformed cells as compared to EpH4 cells. To rule out that the uniform proliferation rates in 2D culture were due to serum or the absence of collagen/matrigel, cells were seeded at different densities on collagen/matrigel-coated dishes, using the same serum-free media as for the 3D cultures. Proliferation rates were determined by [ 3 H]-TdR incorporation as above. Again, the empty vector-and Ras or Her-2 * -expressing cells proliferated with comparable rates (Figure 1c) .
Finally, we analysed whether the differences in proliferation between standard 2D and 3D cultures were reflected by expression of cell cycle regulators. In collagen gels, both non-transformed and Ras-or Her-2 * expressing EpH4 cells showed high expression levels of p21 CIP/WAF , while cyclins D1 and E were highly expressed only in the Ras-or Her-2 * -transformed cells, but not in the control EpH4 cells (Figure 1c ). In contrast, p21 was hardly expressed in any of the cells (except Her-2 * ) on plastic, while cyclin D and E were expressed at uniform, relatively high levels.
These results indicate that epithelial cells maintained in 3D organotypic cultures readily display Ras/Her2 * -induced hyperproliferation and cyclin D1 upregulation. In contrast, Ras or Her-2 * failed to cause hyperproliferation under various 2D culture conditions, except a moderate enhancement seen with one v-H-Ras-expressing clone.
Titration of Ras effector pathways with specific inhibitors
To investigate the contribution of Ras downstream pathways to the observed, enhanced proliferation of Ras-transformed EpH4 cells in collagen gels, two wellcharacterized, specific low MW inhibitors of PI3K (LY294002) and MEK-1 (PD98059) were employed. First, we determined to what extent different concentrations of these compounds would inhibit the activity of both Ras effectors, and for what time inhibitor effects would persist after addition of single inhibitor doses. For this, 2D culture conditions most closely resembling 3D collagen gel cultures (thin layer collagen coating plus serum free media, see Materials and methods) were used. Inhibitor treatment of the cells was initiated 16 h after seeding. The inhibitors were added 6 -48 h before lysis, allowing extract preparation at the same time.
Five mM LY294002 were sufficient to reduce Akt phosphorylation levels (as a measure for PI3K activity) down to the level of parental EpH4, lacking oncogenic Ras (Figure 2a , Western blots quantitated by densitometry). This inhibition, however, declined with time, i.e. Akt phosphorylation was restored partially within 12 h and almost completely within 24 h. However, addition of the compound every 8 -12 h resulted in stable reduction of elevated PI3K signaling to basal levels ( Figure 2a) . Addition of 30 mM LY294002 reduced Akt phosphorylation to almost undetectable levels, an effect that was stable for 424 h (Figure 2a) . At 10 mM, the Mek-1 inhibitor PD98059 reduced the elevated Mek-1 activity levels (measured as Erk1/2 phosphorylation) to the basal levels seen in EpH4 cells after 6 and 12 h (Figure 2b ). This level of inhibition persisted for 24 h. Thirty mM PD98059 reduced Erk phosphorylation to undetectable levels for up to 48 h (Figure 2b ). Based on these experiments, inhibitor concentrations and re-addition schedules could be set up which ensured sustained reduction of the elevated MAPK-and PI3K pathway activities levels in the Ras or Her-2 * transformed cells to the basal levels typical for non-transformed EpH4 cells.
Ras-induced hyperproliferation of EpH4 cells requires activation of the PI3K pathway, but not of the MAPK pathway Next, we determined the effects of the Mek-and PI3K inhibitors on hyperproliferation induced by Ras in 3D collagen cultures, using the conditions determined above (see Figure 2) . v-H-Ras transformed EpRas cells and Her-2 * cells were allowed to form tubular structures in collagen matrices for 4 -6 days, treated with the specific inhibitors for a further 20 or 68 h and proliferation inhibition determined by [
3 H]-TdR incorporation (see Materials and methods). Five mM LY294002 added at 8 h intervals, strongly inhibited proliferation, both after 24 and 68 h of inhibitor treatment ( Figure 3a left and right panels). In contrast, 10 mM PD98059, reducing Erk1/2 phosphorylation levels down to basal levels of EpH4 cells, had no significant or slightly inhibitory effects (*30% reduction) on proliferation after 28 and 68 h of inhibitor treatment, respectively. Thymidine incorporation levels in empty-vector-infected EpH4 cells, treated or not treated with LY294002 or PD98059 for 68 h, were in the same range as LY294002-treated EpRas cells ( Figure 3b) . Interestingly, the inhibitors had similar effects on cells cultured on plastic in 5% FCS. The PI3K inhibitor LY294002 but not PD98059 strongly reduced the proliferation rate of EpRas cells ( Figure 3b ). Next, we analysed whether Ras-dependent cyclin upregulation was also specifically inhibited by LY294002. Twenty hours of treatment with 5 mM LY294002 (added every 8 h) completely suppressed cyclin D1 expression, in line with its inhibitory effect on proliferation, while 10 mM PD98059 hardly affected . EpH4 cells (E; Ep) and EpRas cells (R; Rp) were seeded on plastic coated with thin layer collagen (E; R) or on untreated plastic (Ep; Rp). All the cell samples were cultured for 48 h and lysed at the same time, adding inhibitors 48, 24, 12, and 6 h before lysis as indicated. Below the total times of inhibitor treatment indicated as 'Start treatment (h)' the numbers 24, 12 or 8 indicated as 'interval treatment, (h)' refer to continuous treatment with inhibitors for 48 h, adding fresh inhibitors at intervals of 24, 12 or 8 h respectively. Lysates were processed for Western blot analysis using phospho-specific antibodies to Akt/PKB (P-Akt/PKB) (a) or to Erk1/2 (P-ERK1/2) (b) or respective non-phosphospecific antibodies (Akt/PKB; ERK-1/2). Results from densitometric quantitation of the Western blot signals (normalized for total Akt protein levels) are shown below the phospho-Akt lanes (relative units). The values for phosphoErk (arbitrary units) shown below the phospho-Erk lanes were not normalized to total Erk levels since these seemed to be oppositely affected by the inhibitors as compared to the phospho-Erk expression levels were calculated from the data from six collagen gels. Empty vector controls cells (pLXSN) were likewise inhibitor-treated for 68 h (two gels only). (b) In a parallel experiment to a, the effects of inhibitors on steady-state proliferation on plastic was measured by counting cells after trypsinization and calculating average, cumulative cell numbers from two different cultures. (c) Downregulation of cyclin D1 by PI3K (LY) inhibitor, but not by Mek-1 inhibitor (PD). Ras-and Her2 * cells were cultivated in collagen gels for 6 days, treated with inhibitors for 24 h as in (a) and expression of cyclins and cdk-inhibitors determined by Western blot analysis. (d) Effects of the inhibitors on TGFb-induced EMT in EpRas cells seeded onto permeable filters as measured by Northern blot analysis of EMT marker genes. Inhibitor treatment was initiated 12 h before addition of TGFb (2 ng/ml) and cells were processed for Northern blot analysis 24 h later cyclin D1-and E-levels measured in Ras-and Her-2 * -transformed cells in 3D cultures (Figure 3c) .
Previously, we demonstrated that the Mek-1 inhibitor PD98059, but not LY294002 prevented TGFbinduced EMT of EpRas (v-H-Ras) cells in collagen gels (Janda et al., 2002) . We used this property of PD98059 to demonstrate that its failure to inhibit proliferation was not due to lack of efficacy under the conditions used. EpRas cells were seeded on permeable culture insets and treated with TGFb plus the same concentration of inhibitors as above. Twenty-four hours later total RNA was isolated and Northern blots hybridized with cDNA specific to two EMT markers. As expected, TGFb caused upregulation of mRNA for both the mesenchymal marker Vimentin and the invasivenessrelated marker uPa. Ten mM PD98029 but not 5 mM LY (added every 8 h) prevented upregulation of both EMT markers (Figure 3d ) and caused phenotypical inhibition of EMT (not shown). Conversely, PD but not LY caused a partial downregulation of E-cadherin (measured in Western blots, data not shown). These results suggested that Ras-induced hyperproliferation and EMT are separately regulated by the PI3K-and MAPK-pathways, respectively.
Selective activation of PI3K by Ras effector-specific mutants is sufficient to elicit hyper-proliferation in collagen matrices
To substantiate the above findings and to compare the effects of Ras downstream signaling pathways on hyperproliferation in 3D cultures with tumor growth in vivo, we employed EpH4 cells expressing the effector-specific Ras mutants S35V12Ras and C40V12Ras (Rodriguez-Viciana et al., 1997). Selective activation of Raf/MAPK by S35V12Ras and PI3K/Akt by C40V12Ras has been demonstrated in several independent systems including ours (Gire et al., 1999; Janda et al., 2002; Webb et al., 1998) . We therefore wanted to determine the effects of preferential activation of the PI3K-or MAPK pathways on proliferation of EpH4 cells in collagen gels. To avoid adaptive changes in the proliferative behavior of single cell clones (possibly induced by prolonged cultivation of the cells on plastic), EpH4 cells were infected with high-titer retroviral constructs expressing V12Ras, S35V12Ras or C40V12Ras and drug selected for 5 days. The resulting populations of drug-resistant cells were expanded for another 3 -4 days and seeded into collagen gels without further subculturing at equal cell densities (see Materials and methods). Aliquots of the cells seeded were analysed in Western blots, showing comparable, moderately elevated expression levels of the three Ras mutant proteins, as compared to empty vector controls. However, all three proteins were expressed at much lower levels than v-H-Ras in the EpRas cells used as positive controls (Figure 4a ).
Proliferation in 3D collagen gels was again determined by [
3 H]-TdR incorporation 3 days (Figure 4b , left panel) and 6 days after seeding (data not shown). At both times, we observed a strong increase in proliferation caused by fully active V12Ras expression (Figure 4b , left panel), again leading to overgrowth of the collagen matrices by inflated tubular structures at day 12 ( Figure  4d , panel V12). EpH4 cells expressing C40V12Ras showed a comparably strong proliferative response and outgrowth of epithelial tubules in collagen gels (Figure 4b left; d, panel C40) . In contrast, S35V12Ras expression caused only a weak proliferative response, similar to control empty vector cells (Figure 4b, left) . This was in line with much weaker outgrowth of tubular structures in the collagen gels 12 days after seeding, (Figure 4d , panels S35 and Control). Interestingly and in agreement with the results in Figure 1 , all V12 and Ras mutants pools as well as empty vector cells proliferated with the same kinetics under standard 2D culture conditions on plastic (Figure 4b, right panel) .
To confirm the [ 3 H]-thymidine incorporation data by an independent method using intact gel structures, freshly infected and selected Ras mutant cells were seeded into collagen/matrigel cultures, and incubated with BrdU for 24 h 3 days after seeding. BrdU positive and negative cells visualized by immunofluorescence were then counted in 4500 cells (Figure 4d , insets). In line with the thymidine incorporation data, V12Ras-and C40V12Ras cell structures contained &two to three times more BrdU positive cells than S35V12Ras-or empty vector control structures.
We previously reported that EpH4 cells and S35V12Ras-cells are more sensitive to pro-apoptotic stimuli (e.g. anoikis caused by low density) than V12Ras cells (Janda et al., 2002) . To rule out different levels of background apoptosis as a reason for the observed differences in proliferation rate, we performed TUNEL assays on pools of Ras mutant cells in collagen gels 14 h and 6 days after seeding. Indeed, no significant differences in the apoptotic indices were observed (Figure 4c) , indicating that the different rates of [ 3 H]-TdR incorporation reflected differences in proliferation and not cell death.
Together with the inhibitor data, these results clearly show that PI3K is the major Ras effector responsible for hyperproliferation of Ras-transformed mammary epithelial cells in 3D cultures, stressing the importance of such cultures for analysis of epithelial cell transformation.
High tumor incidence and growth rate correlate with preferential activation of the PI3K pathway, but not the MAPK pathway Next, we analysed whether the strong hyperproliferation exhibited by V12-and C40V12Ras-EpH4 cells in 3D cultures would be reflected by similarly enhanced rates of tumor growth caused by these cells in vivo.
Aliquots from the same cell populations as used for 3D proliferation analysis (Figure 4) were injected into the mammary gland fat pads of nude mice and tested for tumorigenicity and tumor growth rates. In three experiments, using different retroviral stocks and batches of EpH4 cells, V12Ras and C40V12Ras cell populations formed fast growing tumors (Figure 5b,c and data not shown), showing slightly decreased tumor incidence and growth rates in case of C40V12Ras-derived tumors. In contrast, S35V12Ras cells formed only very small nodules that in most cases did not visibly increase in size during the first 10 weeks. After 16 -20 weeks, however, all S35 injection sites gave rise to normal-sized but slow-growing tumors, in clear contrast to the tumor-negative animals receiving control empty vector-EpH4 cells (Figure 5a ). In conclusion, rapid tumor growth requires a Rashyperactivated PI3K pathway in this model, while Ras-activated MAPK causes only very slow tumor growth.
Preferential activation of the MAPK pathway induces EMT in vivo but not rapid tumor growth
The much faster growth kinetics of C40V12Ras expressing EpH4 cells and tumors in vitro and in vivo, as compared to the results obtained with S35V12Ras cell and tumors, raised the question whether other aspects of malignancy, i.e. EMT in vivo and invasiveness, would also be correlated with rapid tumor growth. A reliable marker for acquisition of EMT and invasive properties during human and murine tumor progression is the loss of E-cadherin (Frixen et al., 1991; Perl et al., 1998) , sometimes correlated with upregulation of the mesenchymal marker Vimentin (Oft et al., 1996; Putz et al., 1999) . Frozen sections of tumors obtained by injection of EpH4 cell pools expressing V12Ras, C40V12Ras or S35V12Ras (see Figure 5 ) were first analysed by immunofluorescence for expression of E-cadherin, vimentin and cytokeratin (as a marker for epithelial tumor cells before and after EMT; Oft et al., 1996 Oft et al., , 1998 . C40V12Ras tumors consisted entirely of cells expressing E-cadherin and cytokeratin, while vimentin was only expressed on stromal, cytokeratin-negative cells (Figure 6a , left 
in the insets
Oncogenic Ras mediates proliferation and tubulogenesis through PI3K/Akt E Janda et al panels). In contrast, the much slower growing S35V12Ras tumors contained multiple E-cadherin negative, cytokeratin/vimentin positive areas ( Figure  6a , right panels). Similar results were obtained for the rapidly growing, V12Ras-expressing tumors (not shown). This suggested that many cells within the slow-growing S35V12Ras tumors undergo dedifferentiation typical of EMT in vivo, while all epithelial cells in the fast-growing C40V12Ras tumors maintain their polarized, epithelial phenotype.
We then sought to confirm these data biochemically. Small tissue fragments taken from randomly chosen areas of the tumors were dispersed, the ex-tumor cells neomycin-selected for 1 week and cultivated for a further 2 days without selection. V12Ras-and Ecadherin expression levels were then determined by Western blot analysis of respective cell lysates. In V12Ras ex-tumor cells, high levels of Ras-expression were strongly correlated with a fibroblastoid phenotype and complete loss of E-cadherin expression, while cultures expressing lower Ras levels retained both Ecadherin and an epithelial phenotype (Figure 6b) . Similarly, S35V12Ras ex-tumor cells expressing high levels of the mutant Ras protein showed loss of Ecadherin and mesenchymal morphology (Figure 6c,  right) . However, C40V12Ras ex-tumor cells always maintained E-cadherin expression and epithelial morphology, even in the presence of high levels of C40V12 Ras (Figure 6c, left) . These results demonstrate that PI3K-induced hyperproliferation and rapid tumor growth on the one hand, and MAPK-induced EMT in vitro and in vivo on the other, occur independently of each other, both in vitro and in tumor-bearing animals.
Discussion
Ras-induced hyperproliferation of polarized epithelial cells: why only visible under in vivo like culture conditions?
One major finding of this study was that tumor formation in vivo by Ras-or Her2 * -transformed EpH4 cells correlated with the ability of these cells to hyperproliferate as organotypic tubular structures in three-dimensional (3D) collagen/matrigel matrices. In contrast, neither Ras or Her-2 stimulated proliferation of EpH4 cells on plastic (2D cultures), even if collagencoated dishes plus serum-free media as in the 3D cultures were employed (Figure 1c) . Similar results were obtained by others in primary Ras-and middle Ttransformed human mammary epithelial cells (HMEC), which were tumorigenic and formed colonies in soft agar, but showed no differences in proliferation rate and cell cycle parameters compared to control empty vector cells (Elenbaas et al., 2001) .
How could one explain this differential control of epithelial cell proliferation under 3D and 2D culture conditions? Firstly, cell proliferation is negatively regulated by functionally active E-cadherin present in adherens junctions, possibly due to upregulation of p21 CIP/WAF (see Figure 1c) and/or p27 KIP1 (PerezRoger et al., 1999; Stockinger et al., 2001) . This Ecadherin-dependent cell cycle arrest may be relieved by oncogenic Ras, which weakens cell/cell adhesion and thus E-cadherin signaling (Jechlinger et al., submitted). However, E-cadherin-rich adherens junctions are abundant only in the organotypic tubules formed in 3D cultures, while they are rare in the sparsely seeded partially depolarized epithelial cells in 2D cultures on plastic. Therefore, E-cadherin-dependent cell cycle inhibition and its reversal by oncogenic Ras may explain both hyperproliferation of Ras-transformed cells in 3D cultures and the absence of this effect in 2D cultures. These differences between 2D and 3D cultures may be enhanced by insufficient responses to nutrients/growth factors in cells on plastic, since these agents cannot reach the basolateral domains of Western blot analysis of neo-selected cells recultivated from small, randomly isolated V12Ras tumor pieces (V12XT) isolated 5 and 7 weeks after injection. Note that only cell populations highly overexpressing Ras have lost E-cadherin. (c) Western blot analysis as in b, using recultivated tumor pieces from S35V12Ras (S35XT; isolated at weeks 11 and 16) and C40V12Ras (week 11) tumors. E-cadherin is lost in cell populations expressing high levels of S35V12 Ras protein, while cells expressing similarly high levels of C40V12Ras retain E-cadherin at normal levels signaling (Klinowska et al., 1999) are not properly formed, in contrast to organotypic structures in 3D cultures (S Gru¨nert, unpublished results).
The Ras-activated PI3K pathway is required for hyperproliferation of polarized epithelial cells and fast tumor growth A second major finding of this study was that rapid tumor growth in vivo and hyperproliferation of EpH4 cells in 3D cultures both required signaling of oncogenic Ras via the PI3K pathway. Hyperactivation of the Raf/MAPK pathway favored EMT in vivo, but did not enhance proliferation. These results were obtained using both low molecular weight Mek-1 and PI3K inhibitors and effector-specific V12Ras mutants preferentially activating either the PI3K pathway (C40V12Ras) or the MAPK pathway (S35V12Ras). According to current views, both the Raf/MAPKand the PI3K pathway contribute to Ras-dependent mitogenic signals, as shown in multiple other systems involving both normal and Ras/Her-2 oncogenetransformed cells (Cass and Meinkoth, 2000; Gille and Downward, 1999; Gire et al., 1999; Lenferink et al., 2001; Webb et al., 1998) . For instance, neither S35V12Ras nor C40V12Ras was sufficient for focus formation of 3T3 cells in soft agar (Rodriguez-Viciana et al., 1997), or to stimulate S phase entry upon microinjection in quiescent fibroblasts (Joneson et al., 1996) . Our results, however, do not really disagree with these findings, since we compared enhanced PI3K-or MAPK-signaling caused by oncogenic Ras-proteins with the respective basal levels typical of nontransformed cells. In contrast, most other studies addressed the effects of complete inhibition or abolishment of the pathways in question (Gille and Downward, 1999; Lenferink et al., 2001) .
Oncogenic Ras is only rarely activated in human breast cancer (&5% of breast tumors) while amplification of wild-type Ras and Her-2 are frequent events in breast cancer (440% of breast cancer cases; see Oft et al., 1996) . In line with this, expression of Her-2 * in our cell system similarly induces hyperproliferation and enhanced tubulogenesis in collagen matrices as V12Ras. Although the Her-2 * -downstream signaling pathways responsible for hyperproliferation could not be identified due to the lack of respective Her2 * mutants, a clear link of Her-2 activated PI3K signaling to mitogenic stimulation exists in various cell types. PI3K and PKB/Akt are activated by overexpression and ligand (heregulin) stimulation of Her-2/neu in nontumorigenic cells, as well as in ErbB-2 overexpressing human carcinoma cell lines (Ram and Ethier, 1996; Yu et al., 1998; Zhou et al., 2000) . Furthermore, the tumor suppressor PTEN, a PIP3 phosphatase inhibiting PI3K-and PKB/Akt-signaling, is frequently mutated in breast cancers and re-expression of PTEN inhibits growth and induces anoikis in breast cancer cell lines (Lu et al., 1999) . Finally, PKB/Akt directly phosphorylates the cdk inhibitor p21 in 3T3 fibroblasts and breast cancer cells overexpressing Her-2, thus directly implicating Akt in proliferative responses to Her-2 (Zhou et al., 2001 ).
The Ras-activated Mek/MapK pathway causes EMT in vitro and in vivo, independent of proliferation responses Recently, we showed that a hyperactive Mek/MAPK pathway is required for EMT, local invasion and metastasis (Janda et al., 2002) . In this study, selected clones showing extreme overexpression of the S35V12Ras or C40V12Ras proteins were used, which caused very strong hyperactivation of the MAPK-or PI3K-signaling pathways, respectively. These clones showed similar in vitro-proliferation-and in vivo-tumor growth rates (Janda et al., 2002) . In contrast, intermediate overexpression of Ras-and Ras-mutant proteins yielding moderately enhanced MAPK-or PI3K-signaling (Figures 2 and 4a ) allowed us to demonstrate, that the MAPK-and PI3K-pathways independently induce EMT in tumors and enhanced in vitro/in vivo proliferation, respectively. Elevated PI3K signaling is associated with fast in vitro proliferation and in vivo tumor growth, but unable to cause EMT in vitro or in vivo. In contrast, elevated MAPK signaling caused EMT in vivo, despite the fact that it caused only slow tumor growth (Figures 5 and 6) .
Similarly distinct activities of the MapK-and PI3K-pathways were recently observed in vertebrate cells as well as Drosophila, suggesting PI3K to be involved in mitogenic signaling while the MAPK pathway affects cell differentiation or cell fate. In thyroid epithelial cells, activated Akt alone caused increased proliferation, while TSH induced differentiation required the MAPK-pathway (Cass and Meinkoth, 2000; De Vita et al., 2000) . In Drosophila development, a cooperation of TGFb-like pathways with EGFR-signaling was involved in endoderm induction (Szuts et al., 1998) , while the PI3K pathway regulated organ size (Leevers et al., 1996) , similar to regulation of heart size in transgenic mice expressing constitutively active PI3K (Shioi et al., 2000) .
To our knowledge, such a complete dissection of proinvasive and proliferogenic effects in a combined in vitro/in vivo tumor model, caused by distinct downstream signaling pathways activated by an oncogene, has not been reported before.
Materials and methods

Cell culture
EpH4 mouse mammary epithelial cells and their Rastransformed derivatives EpRas or V12Ras cells were cultured in Eagle's medium containing 10% or 5% FCS (Gibco BRL) respectively, Penicillin/Streptomycin, 20 mM HEPES. Phoenix cells were cultured in DMEM, 10% FCS supplemented with glutamine 2 mM and used for high titer retrovirus production. Tumor cells were obtained after fine mincing of tumor explants and 7 days selection in G418 800 mg/ml (days 2 -8). Cells isolated from tumors (ex-tumor, XT cells) were cultured in 15% FCS Eagle's medium. For the first 2 days TGFb was added at 2 ng/ml concentration to facilitate ex-tumor cells outgrowth. Subculturing was performed every 2 or 3 days at the ratio 1 : 3 for epithelial cells and ratio 1 : 2 for Phoenix and XT cells.
Thin layer collagen coating
Tissue plastic dishes were covered with 50 mg/ml collagen plus 50 mg/ml matrigel in ice-cold 0.02 M acetic acid (1 ml/ 10 cm of dish diameter) and incubated for 2 h at RT. The excess of collagen solution was aspirated and dishes washed twice with PBS.
Collagen/matrigel gels Serum-free organotypic cultures were prepared as previously described (Oft et al., 1996) with minor modifications. Briefly, 12 000 cells were suspended in 300 ml standard growth medium, mixed with 150 ml ice-cold rat tail collagen type I solution (Becton and Dickinson cat #40236, 4.5 mg/ml, final conc. 1.5 mg/ml) plus 20 ml of ice cold, growth factor depleted Matrigel (Becton and Dickinson, cat #40230). Drops (0.1 ml) were placed into the wells of 17 mm 4-well plates (NUNC). After incubation at RT for 30 min and at 378C for 4 h the gels were overlaid with 0.5 ml serum-free medium (Mammary Epithelial Basal Medium, Promocell) supplemented with growth factors according to the instructions of the manufacturer. Medium changes were performed every 2 days. LY294002 and PD98059 were purchased from Calbiochem and re-added every 24 or 8 h at concentrations between 5 and 30 mM.
Constructs and gene transfer
Retroviral vectors of V12Ras and its mutants in pLXSN were previously described (Rodriguez-Viciana et al., 1997) . V12Ras and the V12Ras with mutations S35 or C40 were generated by retroviral infection with high titer virus stocks obtained from the Phoenix cell line according to standard procedures and as described earlier (Janda et al., 2002) , but epithelial cells were seeded on permeable cell culture insets the day before infection.
Reagents and antibodies
Polyclonal rabbit anti E-cadherin (K84; a kind gift of R Kemler, Freiburg, Germany), monoclonal anti-cytokeratin 18 (Progen, #61028), goat anti-vimentin (Santa Cruz, #sc-7557) and mouse anti-BrdU (BMC9318; Boehringer Mannheim, Germany #1170376) antibodies were used for immunofluorescence. Mouse Anti-pan-Ras (Calbiochem #OP40) and antipanRas Val12 antibody with increased specificity to oncogenic V12Ras (Calbiochem, cat #OP38); rabbit anti-phosphoErk and anti-phospho-Akt antibodies as well as anti-Erk1/2 and Akt (#9270 and #9100, New England Biolabs), polyclonal rabbit anti-p21 (Santa Cruz, #sc-471), mouse cyclin D1 (Santa Cruz, #sc-246), polyclonal rabbit anti-cyclin E (Upstate 06-459) were used for Western blotting. Quantitation of phospho-Erk/phospho-Akt Western blot signals was performed by densitometry (BioRad GelDoc2000) using the 'Quantity One' software.
Protein analysis from cells in collagen gels
Collagen gels were digested with 0.4 ml collagenase (Sigma) solution (4 mg/ml in PBS) for 10 min at 378C. Cells from digested and pooled liquefied gels (3 -12 gels per lysate) were spun down, washed twice in PBS and lysed in 60 -200 ml SDS lysis buffer (10 mM Tris-HCl (pH 7.6), 150 mM NaCl, 0.5 mM EDTA, 1 mM EGTA, 1% SDS plus cocktail of protease inhibitors Complete TM (Boehringer Mannheim, Germany), heated for 15 min at 928C, and centrifuged for 10 min at 14 000 g. Protein concentration was determined by MicroBCA TM Protein Assay Reagent Kit (Pierce Cat #23235), and 20 mg of total lysates loaded per lane. SDS -PAGE and immunoblotting were performed according to (Ham et al., 1995) . Cells grown on plastic as controls for cells grown in collagen gels were processed similarly. Cells used for detection of phosphorylated proteins after inhibitor treatment (10 mM PD98059 added every 24 h, 5 mM LY294.002 added every 8 -12 h, see above) were cultured on collagen coated dishes (see above) and lysed with kinase buffer with freshly added inhibitors (10 mM Tris pH 7.6, 50 mM NaCl, 1 mM EGTA, 1% Triton X-100, 50 mM NaF, 30 mM sodium pyrophosphate, 10 mM Na 3 VO 4 , 2 nM ocadoic acid, 10 mM Pefablock and cocktail of inhibitors Complete TM (Boehringer Mannheim, Germany). Total lysates were analysed by 8 -10% SDS -PAGE and immunoblotted as above. V12Ras expression was analysed accordingly but using 12% SDS -PAGE.
Northern blot analysis
EpRas cells were seeded on porous filter supports (Janda et al., 2002) , until &80% confluent and aliquots treated with inhibitors for 36 h (10 mM PD98059 added every 24 h, 5 mM LY294.002 added every 8 -12 h, see above), 24 h before lysis, the inhibitor-treated-and control cells were treated with TGFb (2 ng/ml) and total mRNA prepared using Trizol reagent (Invitrogen). Thirty to 50 mg of total mRNA were processed for Northern blot analysis and hybridized with cDNAs probes for vimentin, uPA and GAPDH as described earlier (Oft et al., 1996) .
TUNEL assay in collagen gels
Cells were seeded at a density of 3000 cells/gel. At specific time points after seeding collagen gels were washed in PBS, fixed with 4% PFA and TUNEL assay (Roche) was performed as described earlier (Janda et al., 2002) . TUNEL positive cells (FITC-labeled) were scored against DAPI stained nuclei by fluorescence microscopy. At least 1000 cells from three to six randomly chosen fields in each collagen gel were counted. The average from two or three collagen gels was used to calculate apoptotic index and standard deviation.
Proliferation assays -thymidine incorporation
Cells from collagen/matrigel gels Media were supplemented with 3 mCi/ml [ 3 H]-thymidine and gels incubated for 20 h. These were washed in PBS and digested with 0.4 ml 4 mg/ml collagenase (Sigma) for 20 -30 min at 378C. Digested, liquefied gels were carefully collected, the cells pelleted, resuspended in 100 ml PBS and finally transferred to a 96-well plate for radioactivity determination, using an automated cell harvester (Tomtec) to harvest the cells onto glass fiber filters. The cell-bound radioactivity was determined in a 96-well scintillation counter (Wallac, Microbeta 1450). For normalization, two additional, representative gels from each cell type and experiment were digested, the cells harvested, washed twice and finally lysed in 50 ml SDS lysis buffer. Protein content was analysed as described above and used to normalize the mean, incorporated radioactivity to protein content.
Oncogenic Ras mediates proliferation and tubulogenesis through PI3K/Akt E Janda et al Cells from plastic or collagen coated substrata Cells were seeded onto 96-well plates (400 000/plate) in 5% FCS. Eight hours later the media were replaced if necessary to serumfree, BPE media (see above). Three mCi/ml [ 3 H]-thymidine was added 24 h later and incubated for 6 h if cultured in FCS or 20 h if cultured in serum-free, BPE containing media. Cells were trypsinized, harvested and processed for radioactivity determination as above. For normalization to protein content, cells from extra wells not subjected to thymidine incorporation were processed for protein determination as above.
BrdU incorporation in collagen I gels
After incubation for 24 h with 10 mM BrdU, the gels were washed with PBS and fixed in 4% PFA, 0.2% Tween for 1 h. DNA was denatured by treatment of the gels with 1 M HCl at 378C for 1 h and neutralization in 0.1 M sodium borate solution (pH 8.0). Thereafter, the gels were washed twice in PBS, blocked for 1 h in 0.2% gelatin in PBS and finally incubated with 6 mg/ml Anti-bromodeoxyuridine antibody (mouse, Boehringer Mannheim #1148818) for 2 h. Thereafter, the gels were washed twice with PBS, incubated for 1 h with Anti-Mouse Alexa TM 565 Antibody (1 : 300 dilution, Molecular probes) and again washed three times in PBS. The nuclei were counterstained with DAPI 1 : 10 000 (1 mg/ml stock) added to the last washing fluid. The gels were carefully spread onto glass slides, mounted in Moviol and analysed by fluorescence microscopy. Quantification of BrdU positive cells was performed by counting BrdU-and DAPI stained nuclei, evaluating at least two gels by taking four photomicrographs (magnification 206) from four different fields of each gel per experimental point. These data were used to calculate the mean percentages of BrdU-positive cells and standard deviations.
Tumorigenesis induction
For tumorigenicity assay, Balb C athymic nude (nu/nu) 5 -9-week-old mice were used, purchased from Charles River Wiga GmbH (Germany). At least three animals were used for each cell type in one experiment. Confluent cells were trypsinized, washed three times in PBS and suspended at 10 5 cells per 25 ml in PBS. Mice were anesthetized with Metofane and 25 ml cell suspension was injected into the fourth and third pair of mammary glands by performing a shallow injection into the nipple area. By this procedure initial nodules were almost in all cases confined to the mammary fat pad. Primary tumor growth was measured with a caliper in mm as length (1) per width (w) (if different) weekly. The mean tumor diameter was calculated according to the formula H(16w). Animals were sacrificed before the tumor reached 20 mm in diameter. Tumor cells were recultivated as described in (Janda et al., 2002) .
Immunofluorescence staining of tumor sections
Tumors or their fragments were fixed overnight with 4% PFA in HBS+ (supplemented with 10 mM CaCl 2 and 1 mM MgCl 2 ). PFA was carefully removed, the tumor pieces sequentially incubated for 2 h in 12%, 15%, and 18% sucrose for each time and embedded in OCT. 7.5 mm frozen sections intervals cut on the cryostat were spread on glass slides, permeabilized with ice-cold methanol/acetone 1 : 1, 15 min at 7208C, blocked in blocking solution (1% BSA in 16HBS+ plus 20 mg/ml non-immune bovine or goat IgG and 0.1% Tween 20) to prevent nonspecific staining and stained with primary antibody diluted using blocking solution, incubating the sections for 1 h in a humid chamber covered with parafilm. The sections were washed three times in HBS+ on a gently rocking platform and incubated with secondary antibody (again diluted in blocking solution) for 0.5 h. After additional three washes including one with DAPI the slides were mounted in Moviol. Confocal analysis was performed on a Leica-TCS-NT confocal microscope and the images were taken using alternating mode to minimize the channel interference.
